US set to drop daily alcohol limit from dietary guidelines: Report

The updated Dietary Guidelines for Americans, which could be released as early as this month, are expected to include a brief statement encouraging Americans to drink in moderation
Reuters
US Dietary Guidelines are expected to eliminate the long-standing recommendation that adults limit alcohol consumption to one or two drinks per day, according to three sources familiar with the matter, in what could be a major win for an industry threatened by heightened scrutiny of alcohol's health effects.
The updated Dietary Guidelines for Americans, which could be released as early as this month, are expected to include a brief statement encouraging Americans to drink in moderation or limit alcohol intake due to associated health risks, the sources said.
The guidelines are still under development and subject to change, two of the sources and a fourth individual familiar with the process said.
Currently, the recommendations advise limiting drinking to one serving or less per day for women and two or less for men, widely seen as a moderate level.
Similar guidelines exist in countries such as the United Kingdom, which advises limiting drinking to 14 units per week, while Canada, however, has adopted a more cautious stance, warning that health risks begin to increase after just two drinks per week.
Even moderate drinking is linked to some health risks, such as higher risk of breast cancer, though some studies have also found an association with possible health benefits, such as a lower risk of stroke.
The fourth source said that the scientific basis for recommending specific daily limits is limited, and the goal is to ensure the guidelines reflect only the most robust evidence.
The new guidelines, developed by the US Department of Health and Human Services and the US Department of Agriculture, are closely watched internationally and influence policies ranging from school lunch programs to medical advice.
Neither department responded to requests for comment.
Health Secretary Robert F. Kennedy Jr., a known teetotaler, has remained largely silent on alcohol but has emphasised a focus on whole foods in the upcoming guidelines.
Some alcohol executives had feared a move towards tighter recommendations on alcohol intake as authorities like the World Health Organization upped their warnings about alcohol's health risks.
Former US Surgeon General Vivek Murthy said alcohol consumption increases the risk of at least seven types of cancer and called for warning labels on alcoholic drinks.
Major industry players, including Diageo and Anheuser-Busch InBev, have lobbied lawmakers throughout the review process. Senate records show the companies spent millions on lobbying efforts related to the guidelines and a range of other issues such as tax and trade in 2024 and 2025.
Both companies declined to comment.
Shares in alcohol companies rose shortly after the announcement, with both AB InBev and Diageo's shares hitting an intraday high.
The new guidelines are set to move away from suggesting consumers limit alcohol consumption to a specific number of daily servings, according to the three sources, who asked not to be named in order to speak freely.
One person said the new alcohol-related recommendation will probably be limited to a sentence or two. Another said the existing numbers tied to moderate drinking could still appear in a longer appendix.
While industry representatives have lobbied lawmakers on the guidelines or how they should be decided, some officials and researchers advocated for tighter restrictions.
Reports intended to inform the guidelines have meanwhile drawn different conclusions about alcohol's health effects and the science around this.
'UNHELPFUL'
Science Over Bias, a group representing US growers, producers, distributors and retailers of beer wine and spirits, said the industry has consistently maintained that the guidelines should be determined by sound scientific evidence and free from bias or conflicts of interest.
"Information on responsible alcohol consumption has been part of the Dietary Guidelines for decades and has provided useful guidance for consumers who choose to consume alcohol and their health care providers," the group said.
The guidelines, which are reviewed every five years, have advised drinking in moderation and defined that as no more than one drink per day for women and no more than two for men since 1990.
Eva Greenthal, a senior policy scientist at the Center for Science in the Public Interest, a non-profit focused on nutrition, health and food safety, said the more general language expected in the guidelines was "so vague as to be unhelpful".
Under such a change, the message that even moderate drinking can increase risks, especially for breast cancer, would get lost, she continued.
Two studies were produced to inform the development of the guidelines. The first found that moderate drinking was associated with increased risk of some cancers, but a decreased risk of dying from any cause and some cardiovascular problems like stroke.
The evidence for some other health impacts was insufficient to draw conclusions, it found.
The other report conversely found the risk of dying from alcohol use, including increased risk for seven cancers, begins at any or low levels of alcohol use and increases with higher consumption.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Time of India

2 days ago

• Time of India

'No one has to watch someone they love suffer...': Bill Gates sees hope in the fight against Alzheimer's, and it's deeply personal, 5 years after his father's loss

Bill Gates sees hope in the fight against Alzheimer's: It's deeply personal; 5 years after his father's loss Five years ago, Bill Gates experienced one of the most severe personal losses of his life: seeing his father, William H. Gates Sr., suffer through the heartless advance of Alzheimer's disease. In a stunning new essay on Gates Notes, the Microsoft co-founder vividly remembers, 'Watching my brilliant, loving father go downhill and disappear was a brutal experience.' That experience has since driven his dedication to fighting this ruinous condition, not only through philanthropy, but through sheer technological and scientific push. On the cutting edge of Alzheimer's research today, Bill Gates finds reasons for real hope. Following his visit to Indiana University's School of Medicine in 2024, he was invigorated by what he described as "the latest breakthrough": blood tests that could diagnose Alzheimer's years before signs of the disease show up. Combined with recently approved medications that slightly slow the march of the disease, Gates feels the world is moving closer to a day when no one will have to suffer the agony of losing a loved one. As he states, 'We are closer than ever before to a world where no one has to watch someone they love suffer from this awful disease.' Bill Gates' fight against Alzheimer's is deeply personal Alzheimer's is not only a health or numerical problem for Bill Gates—it's personal. More than 7 million Americans have Alzheimer's today, including almost 1 in 9 individuals aged 65 and older. And although treatment advances have seemed glacial, Gates's path has been a witness to love-driven perseverance. Spurred on by his father's pain and his call to action, Gates has emerged as one of the most vocal voices urging more money, improved tools, and increased urgency in Alzheimer's research. Bill Gates on Alzheimer's: 'This simple blood test could change everything' When Gates visited IU's School of Medicine, he discovered a revolution in the making for Alzheimer's care: blood tests to diagnose Alzheimer's. The tests quantify the amount and ratio of amyloid plaques and tau proteins—Alzheimer's signatures in the brain, years before full-blown symptoms emerge. Early detection : Researchers now recognise that Alzheimer's disease starts as much as 20 years before the development of clinical symptoms. Scalable screening : Rather than expensive PET scans or invasive cerebrospinal fluid analysis, a routine blood draw might become a standard part of checkups. Proactive intervention : Precocious diagnosis by blood tests might lead to treatments that halt intellectual decline before such damage to the brain is permanent. Gates calls these advances a "game-changer"—not only for researchers, but also for families and caregivers who have felt helpless against the advancement of the disease. Two FDA-approved drugs: A modest win with massive implications Encouraging therapy isn't confined to diagnosis. In the past few months, the US Food and Drug Administration has licensed two novel Alzheimer's medications that have been demonstrated to moderately decelerate disease exacerbation. Though not cures, these medications constitute a significant turning point—from symptom treatment to addressing core pathology. Proof of concept : These approvals demonstrate proof of the amyloid hypothesis and lead to further innovation. Strengthened pipeline : Researchers and companies are increasingly likely to invest in comparable treatments, converting optimism into economic as well as health momentum. Gates's enthusiasm is palpable: 'When combined with early diagnostics, I really am excited about the future of treating this disease.' Bill Gates warns: Alzheimer's treatment progress at risk without public funding Despite advances in science, Gates warns of an impending crisis: dwindling public funding. Over the past few months, budgets for the National Institutes of Health and connected research agencies have been trimmed, just when momentum is gaining steam. He argues: This is exactly when investment is most needed. Government grants support large-scale clinical trials and early-stage science that private philanthropy cannot support on its own. Scaling up biotech instruments such as blood tests and treatments necessitates infrastructures which only governments can develop and sustain. 'If we pull back now, all this progress could grind to a halt—and no private initiative can fill that gap,' Gates writes. Bill Gates sees a turning point: 'Alzheimer's no longer feels hopeless' Over the past few years, Alzheimer's seemed like a black hole of despair—until now. Gates spotlights some of the reasons why the tide is turning: Technological convergence : Biomarker analysis enabled by AI, cheap genomic technologies, and wearable tech are improving detection accuracy and affordability. Early diagnosis culture : Screening for Alzheimer's might soon become part of normal healthcare, along with blood pressure and cholesterol tests. Global advocacy : An expanding group of caregivers, scientists, business leaders, and foundations making a difference. Tangible progress : From tests to therapies, the gradual trickle of breakthroughs is turning into a flood, exciting scientists as well as sufferers. Gates's vision: A future free from Alzheimer's tragedy For Bill Gates, fighting Alzheimer's is not about making headlines—it's about saving families the emotional anguish he suffered personally. He dreams of a world where: Early detection technologies detect the disease years before symptoms arise. Targeted treatments halt or slow the disease, maintaining quality of life. Funding and public support fuel a massive research pipeline. In his most passionate sentence, Gates pleads: 'We are on the cusp of turning the tide against dementia.' But he also warns that urgency must be followed by action—more money, more research, more courage in science. Also read | Jeff Bezos' Indian Creek property just got a $105 million neighbour; here's who bought the 'billionaire bunker' land

Indian Express

2 days ago

• Indian Express

Real risk to youth mental health is ‘addictive use,' not screen time alone, study finds

As Americans scramble to respond to rising rates of suicidal behavior among youth, many policymakers have locked in on an alarming metric: the number of hours a day that American children spend glued to a glowing screen. But a study published Wednesday in the medical journal JAMA, which followed more than 4,000 children across the country, arrived at a surprising conclusion: Longer screen time at age 10 was not associated with higher rates of suicidal behavior four years later. Instead, the authors found, the children at higher risk for suicidal behaviors were those who told researchers their use of technology had become 'addictive' — that they had trouble putting it down or felt the need to use it more and more. Some children exhibited addictive behavior even if their screen time was relatively low, they said. The researchers found addictive behavior to be very common among children — especially in their use of mobile phones, where nearly half had high addictive use. By age 14, children with high or increasing addictive behavior were two to three times as likely as other children to have thoughts of suicide or to harm themselves, the study found. 'This is the first study to identify that addictive use is important and is actually the root cause, instead of time,' said Yunyu Xiao, an assistant professor of psychiatry and population health sciences at Weill Cornell Medical College and the study's lead author. Addictive behavior may be more difficult to control during childhood, before the prefrontal cortex, which acts as a brake on impulsivity, is fully developed. Xiao said interventions should focus on the child's addictive behavior, which is typically treated with cognitive behavioral psychotherapy, rather than simply limiting access to screens. 'If there are early warnings, then for parents, it's important to seek professional help for children with such addictions,' she said. 'We do not know if just taking away their phone will help. Sometimes it can create some conflict in the family, and that is even worse.' The focus on addictive behavior has important policy implications, shifting more responsibility onto the technology companies that design devices and social media platforms, said Mitch Prinstein, chief science officer at the American Psychological Association. Policymakers can address addiction by requiring technology companies to introduce 'age-appropriate design' that limits features adolescents find difficult to resist, he said. The United Kingdom introduced a code of this kind in 2020.

New Indian Express

2 days ago

• New Indian Express

What to know about the COVID variant that may cause 'razor blade' sore throats

The COVID-19 variant that may be driving a recent rise in cases in some parts of the world has earned a new nickname: 'razor blade throat' COVID. That's because the variant — NB.1.8.1. or 'Nimbus' — may cause painful sore throats. The symptom has been identified by doctors in the United Kingdom, India and elsewhere, according to media outlets in those countries. Other COVID-19 symptoms of any variant include fever, chills, cough, shortness of breath or loss of taste or smell. Experts say there isn't major cause for concern with the Nimbus variant, but here 's what else you need to know about it. Here's where the variant causing 'razor blade throat' is spreading The rise in cases late last month is primarily in eastern Mediterranean, Southeast Asia and western Pacific regions, the World Health Organization said May 28. The new variant had reached nearly 11% of sequenced samples reported globally in mid-May. Airport screening in the United States detected the new variant in travelers arriving from those regions to destinations in California, Washington state, Virginia and New York. You aren't likely to get sicker from this variant than others Not so far, anyway. The WHO said some western Pacific countries have reported increases in COVID cases and hospitalizations, but there's nothing so far to suggest that the disease associated with the new variant is more severe compared to other variants. COVID-19 vaccines are effective against the Nimbus variant Yes. The WHO has designated Nimbus as a 'variant under monitoring' and considers the public health risk low at the global level. Current vaccines are expected to remain effective. Health Secretary Robert F. Kennedy Jr. announced last month that COVID-19 shots are no longer recommended for healthy children and pregnant women — a move immediately questioned by public health experts.